Supriya Nagaraju

442 total citations
15 papers, 322 citations indexed

About

Supriya Nagaraju is a scholar working on Surgery, Molecular Biology and Urology. According to data from OpenAlex, Supriya Nagaraju has authored 15 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 3 papers in Molecular Biology and 2 papers in Urology. Recurrent topics in Supriya Nagaraju's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Urinary Tract Infections Management (2 papers). Supriya Nagaraju is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Urinary Tract Infections Management (2 papers). Supriya Nagaraju collaborates with scholars based in United States, India and Canada. Supriya Nagaraju's co-authors include Mehdi Nikkhah, Danh D. Truong, Ghassan Mouneimne, Ashish M. Kamat, Nathan A. Brooks, Trinity J. Bivalacqua, Kenneth G. Nepple, Lewis J. Thomas, Donald L. Lamm and Mounica Y. Rao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Supriya Nagaraju

10 papers receiving 316 citations

Peers

Supriya Nagaraju

SURGE

ONCOL

UROLO

Daniel Halloran United States

Neda Dadgar United States

Linda Krisch Austria

Brigitte Tichy Austria

Shui Sun China

Julia Hupfeld Germany

Priyanka Garg India

Masayuki Umeda Japan

Michał Lach Poland

Chootima Ratisoontorn Thailand

Daniel Halloran United States

Supriya Nagaraju

63 ×0.4

SURGE

105 ×0.8

51 ×0.5

ONCOL

123 ×1.6

29 ×0.6

UROLO

Citations per year, relative to Supriya Nagaraju Supriya Nagaraju (= 1×) peers Daniel Halloran

Countries citing papers authored by Supriya Nagaraju

Since Specialization

Citations

This map shows the geographic impact of Supriya Nagaraju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supriya Nagaraju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supriya Nagaraju more than expected).

Fields of papers citing papers by Supriya Nagaraju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Supriya Nagaraju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supriya Nagaraju. The network helps show where Supriya Nagaraju may publish in the future.

Co-authorship network of co-authors of Supriya Nagaraju

This figure shows the co-authorship network connecting the top 25 collaborators of Supriya Nagaraju. A scholar is included among the top collaborators of Supriya Nagaraju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Supriya Nagaraju. Supriya Nagaraju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nagaraju, Supriya, et al.. (2025). Robotic assisted kidney transplantation and its nuances: experience of a high-volume tertiary care centre. Journal of Robotic Surgery. 19(1). 685–685.

Corvigno, Sara, Yuan Liu, Emine Bayraktar, et al.. (2024). Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. npj Precision Oncology. 8(1). 86–86. 18 indexed citations

Nagaraju, Supriya, et al.. (2024). Case study: world’s largest renal myopericytoma—management and literature review. SHILAP Revista de lepidopterología. 1(2).

Thomas, Lewis J., Ryan L. Steinberg, Vignesh T. Packiam, et al.. (2022). Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer.

Bree, Kelly K., Patrick J. Hensley, Nathan A. Brooks, et al.. (2021). MP48-14 UTUC SURVEILLANCE FOLLOWING BCG-TREATED NMIBC: TIMING AND RISK FACTORS ASSOCIATED WITH RECURRENCE. The Journal of Urology. 206(Supplement 3).

Hensley, Patrick J., Kelly K. Bree, Nathan A. Brooks, et al.. (2021). Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes. European Urology Oncology. 5(3). 347–356. 6 indexed citations

Hensley, Patrick J., Nathan A. Brooks, Justin T. Matulay, et al.. (2021). Implications of guideline-based, risk-stratified restaging transurethral resection of HG Ta urothelial carcinoma on BCG therapy outcomes. European Urology. 79. S1055–S1056. 1 indexed citations

Ramalingam, Sakkaraiappan, et al.. (2021). Disseminated BCG Infection after intravesical BCG Immunotherapy of Bladder Cancer. QJM. 114(6). 410–411. 1 indexed citations

Brooks, Nathan A., Supriya Nagaraju, Justin T. Matulay, Xiang-Yang Han, & Ashish M. Kamat. (2020). Bacillus Calmette-Guérin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage. European Urology Oncology. 4(5). 826–828. 7 indexed citations

10.

Nagaraju, Supriya, Jacquelyn Kilbourne, Alan Rawls, et al.. (2020). Poly(N-isopropylacrylamide)-based dual-crosslinking biohybrid injectable hydrogels for vascularization. Acta Biomaterialia. 107. 138–151. 28 indexed citations

11.

Brooks, Nathan A., Andrea Kokorovic, Justin T. Matulay, et al.. (2020). The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus Calmette–Guérin. British Journal of Urology. 128(1). 65–71. 16 indexed citations

12.

Brooks, Nathan A., Supriya Nagaraju, Justin T. Matulay, Xiang-Yang Han, & Ashish M. Kamat. (2020). BCG shortage: Reassessing the clinical viability of Bacillus Calmette-Guerin (BCG) after reconstitution.. Journal of Clinical Oncology. 38(6_suppl). 534–534. 1 indexed citations

13.

Steinberg, Ryan L., Lewis J. Thomas, Nathan A. Brooks, et al.. (2019). Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer. The Journal of Urology. 203(5). 902–909. 119 indexed citations

14.

Matulay, Justin T., Roger Li, Neema Navai, et al.. (2019). MP43-04 CONTEMPORARY OUTCOMES OF NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH INDUCTION BCG. The Journal of Urology. 201(Supplement 4). 1 indexed citations

15.

Nagaraju, Supriya, Danh D. Truong, Ghassan Mouneimne, & Mehdi Nikkhah. (2018). Microfluidic Tumor–Vascular Model to Study Breast Cancer Cell Invasion and Intravasation. Advanced Healthcare Materials. 7(9). e1701257–e1701257. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact